Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Altimmune (ALT) FCF Margin (2016 - 2025)

Altimmune (ALT) has disclosed FCF Margin for 16 consecutive years, with 74803.85% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 29049615.0% to 74803.85% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 164721.95% through Dec 2025, up 23451805.0% year-over-year, with the annual reading at 164746.34% for FY2025, 23449366.0% up from the prior year.
  • FCF Margin for Q4 2025 was 74803.85% at Altimmune, up from 237940.0% in the prior quarter.
  • The five-year high for FCF Margin was 674.82% in Q4 2021, with the low at 755500.0% in Q3 2022.
  • Average FCF Margin over 5 years is 210363.27%, with a median of 150847.32% recorded in 2023.
  • The sharpest move saw FCF Margin crashed -74420570bps in 2022, then skyrocketed 74984061bps in 2023.
  • Over 5 years, FCF Margin stood at 674.82% in 2021, then crashed by -9785bps to 66707.69% in 2022, then surged by 33bps to 44683.78% in 2023, then plummeted by -718bps to 365300.0% in 2024, then soared by 80bps to 74803.85% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 74803.85%, 237940.0%, and 387000.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.